Evidence map›Paper›PMID 37314625›Full record

ArticleJournal of echocardiography2024

Dasatinib-related left ventricular dysfunction in a patient with chronic myelogenous leukemia.

Yuka Kawanami, Kazuto Yamaguchi, Seita Yamasaki, Yuzo Kagawa, Hirotomo Sato, Nobuhide Watanabe, Akihiro Endo, Hiroyuki Yoshitomi, Kazuaki Tanabe

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of echocardiography, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuka KawanamiDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan.
Kazuto YamaguchiDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan.
Seita YamasakiDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan.
Yuzo KagawaDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan.
Hirotomo SatoDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan.
Nobuhide WatanabeDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan.
Akihiro EndoDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan.
Hiroyuki YoshitomiDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan.
Kazuaki TanabeDivision of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo, Japan. kaz@med.shimane-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DasatinibLeukemia, Myelogenous, Chronic, BCR-ABL PositiveVentricular Dysfunction, LeftAntineoplastic AgentsEchocardiographyHumansMaleMiddle AgedProtein Kinase InhibitorsAntineoplastic AgentsDasatinibProtein Kinase Inhibitors

Identifiers

PMID37314625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.